Sanaby Health Acquisition I Overview
Valuation check: SANB's ROE is -88.41%, below the sector sector average of -5.87%.
Get informed when a big investor buys or sells
+ Follow-88.41%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Sanaby Health Acquisition I (SANB) currently reports a ROE of -88.41%. That is below the sector sector average of -5.87%. Use the charts on this page to explore Sanaby Health Acquisition I's ROE history and peer comparisons.
Sanaby Health Acquisition I's ROE of -88.41% is lower than the its sector sector average of -5.87%. That is roughly 1406.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Sanaby Health Acquisition I's current -88.41% should be judged against industry norms (sector average: -5.87%) and against SANB's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -88.41%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -5.87%. From there, open related valuation or income-statement pages for Sanaby Health Acquisition I, and consider following SANB for alerts when major investors trade the stock.
